Explore JAK2/JAK-2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]
| Target ID |
GM-T08391
|
| Target Name |
JAK2/JAK-2
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
3717
|
| Gene ID |
100051487 (Equus caballus), 101088959 (Felis catus), 16452 (Mus musculus), 24514 (Rattus norvegicus) 3717 (Homo sapiens), 484185 (Canis lupus familiaris), 525246 (Bos taurus), 694184 (Macaca mulatta)
|
| Target Alternative Names |
Fd17,JAK-2,JAK2,JTK10,Jak2,Janus kinase 2 (JAK-2),Tyrosine-protein kinase JAK2
|
| Uniprot Accession |
Q62120,Q62689,O60674
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer
|
| Disease from KEGG |
EGFR tyrosine kinase inhibitor resistance, Chemokine signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis
|
| Gene Ensembl |
ENSECAG00000009119, ENSMUSG00000024789, ENSG00000096968, ENSCAFG00845015887, ENSBTAG00000012047, ENSMMUG00000014558
|
| Target Classification |
Kinase, Tumor-associated antigen (TAA)
|
Pre-made viral vector of JAK2/JAK-2 cDNA Clones/ORF Plasmid
JAK2/JAK-2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo3717 | Pre-made Human JAK2/JTK10 siRNA oligo Duplex | 3717 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo24514 | Pre-made Rat Jak2 siRNA oligo Duplex | 24514 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo16452 | Pre-made Mouse Jak2/Fd17 siRNA oligo Duplex | 16452 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo694184 | Pre-made Cynomolgus/Rhesus macaque JAK2 siRNA oligo Duplex | 694184 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101088959 | Pre-made Cat/Feline JAK2 siRNA oligo Duplex | 101088959 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo484185 | Pre-made Dog/Canine JAK2 siRNA oligo Duplex | 484185 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo525246 | Pre-made Bovines/Cattle JAK2 siRNA oligo Duplex | 525246 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100051487 | Pre-made Equine/Horse JAK2 siRNA oligo Duplex | 100051487 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
JAK2/JAK-2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T08391-Ab | Human | Anti-Human JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T08391-Ab | Rat | Anti-Rat JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T08391-Ab | Mouse | Anti-Mouse JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T08391-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T08391-Ab | Cat/Feline | Anti-Cat/Feline JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T08391-Ab | Dog/Canine | Anti-Dog/Canine JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T08391-Ab | Bovines/Cattle | Anti-Bovines/Cattle JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T08391-Ab | Equine/Horse | Anti-Equine/Horse JAK2/JAK-2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
JAK2/JAK-2 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T08391-Ag | Human | Human JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T08391-Ag | Rat | Rat JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T08391-Ag | Mouse | Mouse JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T08391-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T08391-Ag | Cat/Feline | Cat/Feline JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T08391-Ag | Dog/Canine | Dog/Canine JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T08391-Ag | Bovines/Cattle | Bovines/Cattle JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T08391-Ag | Equine/Horse | Equine/Horse JAK2/JAK-2 VLP (virus-like particle) | HEK293 | Products Developing |